Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2015
03/05/2015WO2015031815A2 Antibodies and assays for detection of folate receptor 1
03/05/2015WO2015031693A1 Engineered anti-dll3 conjugates and methods of use
03/05/2015WO2015031681A1 Micronized placental compositions comprising a chelator
03/05/2015WO2015031673A2 Cns-targeted conjugates having modified fc regions and methods of use thereof
03/05/2015WO2015031645A1 Monoclonal antibodies to human 14-3-3 epsilon and human 14-3-3 epsilon sv
03/05/2015WO2015031552A1 Estradiol containing transdermal drug delivery systems and compositions
03/05/2015WO2015031425A1 Compound of glycosaminoglycan and its preparation method as well as application
03/05/2015WO2015031412A1 Testosterone booster transdermal compositions
03/05/2015WO2015031396A1 Pharmaceutical compositions comprising macrolide diastereomers, methods of their synthesis and therapeutic uses
03/05/2015WO2015031284A1 Formulations comprising wetting agents and compounds for the modulation of hemoglobin (s)
03/05/2015WO2015031244A1 A process to produce an aqueous dispersion, an aqueous dispersion produced thereby and a coating composition comprising the aqueous dispersion
03/05/2015WO2015031198A2 Bendamustine pharmaceutical compositions
03/05/2015WO2015031059A1 Ph-sensitive peptides and their nanoparticles for drug delivery
03/05/2015WO2015029926A1 Ophthalmological composition
03/05/2015WO2015029924A1 Ophthalmological composition
03/05/2015WO2015029717A1 Ophthalmic solution
03/05/2015WO2015028966A2 Amino diacids containing peptide modifiers
03/05/2015WO2015028920A1 Ionic gelation on solids
03/05/2015WO2015028850A1 Novel cytotoxic agents for conjugation of drugs to cell binding molecule
03/05/2015WO2015028637A1 Novel drug formulation
03/05/2015WO2015028172A1 Compound of glycosaminoglycan, preparation method and use thereof
03/05/2015WO2015027342A1 Microgel compositions for delivery of substances to the brain
03/05/2015WO2015027322A1 Methods and compositions for treatment of cartilage and disc tissue pathologies
03/05/2015WO2014165093A9 Fibronectin based scaffold domains linked to serum albumin or a moiety binding thereto
03/05/2015US20150065711 Discrete PEG Constructs
03/05/2015US20150065685 Laser-actuated therapeutic nanoparticles
03/05/2015US20150065670 Asymmetric bifunctional silyl monomers and particles thereof as prodrugs and delivery vehicles for pharmaceutical, chemical and biological agents
03/05/2015US20150065586 Amino acid derivatives and absorbable polymers therefrom
03/05/2015US20150065582 Orally Dissolving Formulations of Memantine
03/05/2015US20150065570 Agent for inducing the synthesis of heat-shock proteins in human and animal cells
03/05/2015US20150065558 Glycoconjugates of RNA Interference Agents
03/05/2015US20150065553 Stabilized statin formulations
03/05/2015US20150065549 Bendamustine Pharmaceutical Compositions
03/05/2015US20150065548 Composition comprising an organic diluent and a cellulose ether
03/05/2015US20150065547 Esterified cellulose ethers having a specific substituent distribution
03/05/2015US20150065536 Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydrocodone, Prodrugs, Methods of Making and Uses Thereof
03/05/2015US20150065491 Administration of benzodiazepine compositions
03/05/2015US20150065479 Method for enhancing anti-tumor effect of a microtubule-targeting drug, and a method for treatment of tumor
03/05/2015US20150065474 Dexamethasone formulations in a biodegradable material
03/05/2015US20150065467 Use of lipid conjugates in the treatment of diseases or disorders of the eye
03/05/2015US20150065462 Conjugates of a phospholipid and a drug for the treatment of inflammatory bowel disease
03/05/2015US20150065461 Vesicular Formulations for Use in the Treatment of Pain or Reduced Mobility of a Joint
03/05/2015US20150065453 Combination of an oxidant and a photoactivator for the healing of wounds
03/05/2015US20150065450 Compound of glycosaminoglycan and its preparation method as well as application
03/05/2015US20150065443 Embelin-based delivery system for water-insoluble active agents
03/05/2015US20150065442 Reducible self-assembled micelle drug delivery systems
03/05/2015US20150065426 Testosterone Booster Transdermal Compositions
03/05/2015US20150065423 Rapid acting injectable formulations
03/05/2015US20150065420 Vitamin d-ghrelin conjugates
03/05/2015US20150064283 Pharmaceutical compositions for parenteral administration
03/05/2015US20150064282 Use of neu1 sialidase inhibitors in the treatment of cancer
03/05/2015US20150064275 Compositions for improved tissue oxygenation by peritoneal ventilation
03/05/2015US20150064274 Micronized placental compositions comprising a chelator
03/05/2015US20150064268 Nanoparticles for stimulating elastogenesis
03/05/2015US20150064266 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
03/05/2015US20150064265 Vehicles for Controlled Delivery of Different Pharmaceutical Agents
03/05/2015US20150064259 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
03/05/2015US20150064258 Diclofenac formulations and methods of use
03/05/2015US20150064255 Nanostructures for treating cancers and other conditions
03/05/2015US20150064252 Solid dispersion formulation of an antiviral compound
03/05/2015US20150064248 Abuse resistant forms of extended release hydromorphone, method of use and method of making
03/05/2015US20150064247 Abuse resistant forms of immediate release hydrocodone, method of use and method of making
03/05/2015US20150064243 Pharmaceutical compositions and dosage forms for admininistration of hydrophobic drugs
03/05/2015US20150064242 Trialkyl cationic lipids and methods of use thereof
03/05/2015US20150064238 Method and composition for enhancing the delivery of anti-platelet drugs for the treatment of acute stroke
03/05/2015US20150064233 Lipid-coated nucleic acid nanostructures of defined shape
03/05/2015US20150064231 Oral film containing opiate enteric-release beads
03/05/2015US20150064230 Sustained release delivery of one or more agents
03/05/2015US20150064212 Process for the preparation and use of a bivalent vaccine against morphine-heroin addiction
03/05/2015US20150064205 Enhancement of pathogen-specific memory th17 cell responses
03/05/2015US20150064190 Antibodies to tumor endothelial marker 7r
03/05/2015US20150064181 Antisense conjugates for decreasing expression of dmpk
03/05/2015US20150064166 Lyophilized Preparation of Botulinum Toxin
03/05/2015US20150064164 Tissue disruption treatment and composition for use thereof
03/05/2015US20150064155 Methods for treatment of cervical insufficiency
03/05/2015US20150064130 Protein-polymer-drug conjugates
03/05/2015US20150064124 Personal care formulations containing alkyl ketal esters and methods of manufacture
03/05/2015US20150064118 Lipid depot formulations
03/05/2015US20150064117 Novel polymorphs of rebaudioside c and methods for making and using the same
03/05/2015US20150064116 Multilayered magnetic micelle compositions and methods for their use
03/05/2015US20150064110 Crosslinked polysaccharide beads comprising an imaging agent
03/05/2015US20150064106 Biodegradable Polyphosphazenes Containing Pyrrolidone Side Groups
03/05/2015DE102013109514A1 Reduktion der Zelltoxizität von Bakteriostatika mittels Farbstoffen Reduction of cell toxicity of antimicrobials using dyes
03/04/2015EP2842986A1 Method for producing starch granules, and orally disintegrating tablet
03/04/2015EP2842967A1 Pegylated amyloid beta fab
03/04/2015EP2842942A1 Trans-2-decenoic acid derivative and drug containing same
03/04/2015EP2842576A1 Transglutaminase mediated conjugation of peptides
03/04/2015EP2842575A1 Auristatin drug linker conjugates
03/04/2015EP2842574A1 Sustained release carrier for drugs
03/04/2015EP2842571A1 Antibodies directed to GPNMB and uses thereof
03/04/2015EP2842570A1 Compositions and methods for the prevention and treatment of autoimmune conditions
03/04/2015EP2842559A2 Compounds, compositions and methods for the treatment of viral infections and other medical disorders
03/04/2015EP2842553A1 Analgesic
03/04/2015EP2842549A1 Orally disintegrating tablet and method for producing same
03/04/2015EP2842546A1 Unit structure-type pharmaceutical composition for nucleic acid delivery
03/04/2015EP2842545A1 Method for producing an aqueous dispersion of drug nanoparticles and use thereof
03/04/2015EP2841486A2 Polymeric nanoparticles and a process of preparation thereof
03/04/2015EP2841112A1 Porphyrin-lipid stabilized nanoparticles for surface enhanced raman scattering based imaging
03/04/2015EP2841111A1 A nanosphere - histone acetyltransferase (hat) activator composition, process and methods thereof
03/04/2015EP2841110A1 A method for antigen delivery
1 2 3 4 5 6 7 8 9 10 11 ... 1712